COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy
Sign Up to like & getrecommendations! Published in 2021 at "European Respiratory Journal"
DOI: 10.1183/13993003.03969-2020
Abstract: Background Asthma is a heterogeneous syndrome substantiating the urgent requirement for endotype-specific biomarkers. Dysbalance of fibrosis and fibrolysis in asthmatic lung tissue leads to reduced levels of the inflammation-protective collagen 4 (COL4A3). Objective To delineate… read more here.
Keywords: degradation; col4a3; ige therapy; anti ige ... See more keywords